Healthcare

Novartis AG(NVS)

Live Price

Offline

$155.59

+0.30% today

1Y Change

+25.72%

Window

Jun 27, 2025 → Jun 17, 2026

Market Cap: $282.81B
Revenue Growth: +6.0%
EPS Growth: +22.5%
Dividend Yield: 3.2%

Coverage: 244 bars · Jun 27, 2025 → Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Novartis AG (NVS) is a Healthcare stock with a market cap of $282.81B and listed on NYSE. The stock last traded around $155.59 and up 25.7% across the available one-year price window (Jun 27, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +6.0%, EPS growth of +22.5%, a dividend yield of 3.2%. What stands out right now is revenue +6.0%, EPS +22.5%, free cash flow +28.1% with operating margin 29.9% and ROIC 14.9%. The dividend matters to the case here, with a current yield around 3.2%. Valuation sits in the middle of the pack at P/E 21.0 and price/sales 5.1. Stock Foundry combines NVS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

NVS vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NVS

—

Normalized return

SPY

S&P 500

Excess Return

Relative to SPY

NVS Max Drawdown

-15.23%

Trailing 1Y

SPY Max Drawdown

—

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NVS and SPY.

Calendar-year return history is still loading or unavailable.

Unable to load analyst forecasts.

Timed out loading forecasts for NVS

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.

Read the analyst forecasts guide Compare stocks with this setup